Tonix Pharmaceuticals Holding (TNXP) Assets Average (2011 - 2026)

Tonix Pharmaceuticals Holding's Assets Average history runs 16 years deep, the most recent figure standing at $267.5 million for Q1 2026.

• On a quarterly basis, Assets Average rose 50.41% year-over-year to $267.5 million in Q1 2026; TTM through Mar 2026 was $267.5 million, a 50.41% increase from a year earlier, with the FY2025 full-year figure at $220.0 million, up 38.67% from the prior year.
• Assets Average rose to $267.5 million in Q1 2026 per TNXP's latest filing, from $264.8 million in the prior quarter.
• Across five years, Assets Average topped out at $267.5 million in Q1 2026 and bottomed at $82.6 million in Q3 2024.
• The 5-year median for Assets Average is $190.1 million (2025), against an average of $189.6 million.
• Across the five-year window, Assets Average tumbled 44.72% in 2024 and soared 166.07% in 2025, its largest moves.
• Year by year, Assets Average stood at $234.2 million in 2022, then slumped by 37.28% to $146.9 million in 2023, then dropped by 12.21% to $128.9 million in 2024, then surged by 105.37% to $264.8 million in 2025, then rose by 1.03% to $267.5 million in 2026.
• Per Business Quant, the three latest TNXP Assets Average figures stand at $267.5 million (Q1 2026), $264.8 million (Q4 2025), and $219.9 million (Q3 2025).